Page last updated: 2024-08-23

norgestimate and desogestrel

norgestimate has been researched along with desogestrel in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19904 (10.81)18.7374
1990's23 (62.16)18.2507
2000's9 (24.32)29.6817
2010's1 (2.70)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corson, SL; Kafrissen, ME1
London, RS1
Rebar, RW; Zeserson, K1
Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B1
Hahn, DW; McGuire, JL; Phillips, A1
Roy, S; Stanczyk, FZ1
Back, DJ; Madden, S; Orme, ML1
Chez, RA2
Rabe, T; Runnebaum, B1
Göretzlehner, G; Köhler, G1
Egarter, C; Huber, J; Putz, M; Speiser, P; Strohmer, H; Wenzl, R1
Sobel, NB1
DeCherney, A; Speroff, L1
Back, DJ; Rudland, PS; Wild, MJ1
Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D1
Borm, GF; Coenen, CM; Rolland, R; Thomas, CM1
Teichmann, A1
Amiral, J; Guize, L; Plu-Bureau, G; Scarabin, PY1
Creinin, MD1
Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO1
Schwingl, PJ; Shelton, J1
Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP1
Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R1
Stanczyk, FZ1
Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S1
Milsom, I; Odlind, V; Persson, I; Victor, A1
Kaunitz, AM1
del Marmol, V; Gertsen, K; Teichmann, A1
Baerwald, AR; Olatunbosun, OA; Pierson, RA1
O'Connell, KJ; Osborne, LM; Westhoff, C1
Jick, H; Jick, SS; Kaye, JA; Russmann, S1
Jick, H; Jick, SS1
Burkman, RT; Fisher, AC; LaGuardia, KD1
Buono, MJ; Martin, JG1
Angsuwathana, S; Chaovisitsaree, S; Jaisamrarn, U; Nerapusee, O1

Reviews

13 review(s) available for norgestimate and desogestrel

ArticleYear
Comparative review of third-generation progestins.
    International journal of fertility, 1992, Volume: 37 Suppl 2

    Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Norgestrel; Norpregnenes

1992
The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.
    Obstetrical & gynecological survey, 1992, Volume: 47, Issue:11

    Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners

1992
Characteristics of the new progestogens in combination oral contraceptives.
    Contraception, 1991, Volume: 44, Issue:1

    Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners

1991
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
    Contraception, 1990, Volume: 42, Issue:1

    Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes

1990
Gastrointestinal metabolism of contraceptive steroids.
    American journal of obstetrics and gynecology, 1990, Volume: 163, Issue:6 Pt 2

    Topics: Aged; Biological Availability; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Norgestrel; Norpregnenes; Sulfates

1990
Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
    American journal of obstetrics and gynecology, 1989, Volume: 160, Issue:5 Pt 2

    Topics: Carbohydrate Metabolism; Desogestrel; Drug Evaluation; Female; Humans; Lipid Metabolism; Menstrual Cycle; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners; Proteins

1989
Metabolic aspects of the new low-dose oral contraceptives.
    International journal of fertility, 1989, Volume: 34 Suppl

    Topics: Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Proteins

1989
[New progestational hormones].
    Zentralblatt fur Gynakologie, 1988, Volume: 110, Issue:13

    Topics: Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Progesterone Congeners

1988
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
    Obstetrics and gynecology clinics of North America, 1994, Volume: 21, Issue:2

    Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship

1994
Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins.
    Obstetrics and gynecology, 1993, Volume: 81, Issue:6

    Topics: Androgens; Blood Coagulation; Blood Glucose; Contraceptives, Oral; Desogestrel; Female; Humans; Insulin; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners

1993
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
    Contraception, 1997, Volume: 55, Issue:5

    Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners

1997
Enhancing oral contraceptive success: the potential of new formulations.
    American journal of obstetrics and gynecology, 2004, Volume: 190, Issue:4 Suppl

    Topics: Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel

2004
The role of combined oral contraceptives in the management of acne and seborrhea.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2004, Volume: 9, Issue:2

    Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome

2004

Trials

10 trial(s) available for norgestimate and desogestrel

ArticleYear
[Side effects of oral contraceptives in the first treatment cycle].
    Wiener medizinische Wochenschrift (1946), 1991, Volume: 141, Issue:18-19

    Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies

1991
Ovarian function during low-dose oral contraceptive use.
    Contraception, 1995, Volume: 51, Issue:6

    Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Ovarian Cysts; Ovary; Patient Compliance; Progesterone; Prospective Studies; Smoking; Ultrasonography

1995
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone

1995
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners

1995
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
    Contraception, 1999, Volume: 59, Issue:6

    Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis

1999
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
    Contraception, 2004, Volume: 70, Issue:5

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography

2004
Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
    Contraception, 2005, Volume: 72, Issue:5

    Topics: Administration, Intravaginal; Adolescent; Adult; Analysis of Variance; Body Mass Index; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Weight Gain

2005
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:11

    Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain

2007
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
    Clinical physiology (Oxford, England), 1997, Volume: 17, Issue:4

    Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature

1997
A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial.
    Contraception, 2014, Volume: 90, Issue:5

    Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norgestrel; Treatment Outcome; Young Adult

2014

Other Studies

14 other study(ies) available for norgestimate and desogestrel

ArticleYear
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
    Steroids, 1990, Volume: 55, Issue:8

    Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone

1990
New progestogens in oral contraceptives.
    American journal of obstetrics and gynecology, 1987, Volume: 157, Issue:4 Pt 2

    Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners

1987
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
    The Journal of steroid biochemistry and molecular biology, 1993, Volume: 45, Issue:5

    Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured

1993
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires

1995
Safety of combined oral contraceptive pills.
    Lancet (London, England), 1996, Feb-24, Volume: 347, Issue:9000

    Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Cross-Sectional Studies; Desogestrel; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Norgestrel; Norpregnenes; Progesterone Congeners; Thromboembolism

1996
Laboratory criteria for menopause in women using oral contraceptives.
    Fertility and sterility, 1996, Volume: 66, Issue:1

    Topics: Adult; Aged; Contraceptives, Oral; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pilot Projects; Prospective Studies; Time Factors

1996
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
    Contraception, 1996, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism

1996
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
    Contraception, 1997, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States

1997
Risk of oral contraceptives and recency of market introduction.
    Contraception, 1997, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors

1997
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
    British journal of haematology, 1997, Volume: 97, Issue:1

    Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis

1997
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
    Human reproduction (Oxford, England), 2000, Volume: 15, Issue:4

    Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis

2000
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
    Acta obstetricia et gynecologica Scandinavica, 2002, Volume: 81, Issue:6

    Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis

2002
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Contraception, 2006, Volume: 73, Issue:6

    Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism

2006
Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
    Contraception, 2006, Volume: 74, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Intracranial Thrombosis; Levonorgestrel; Norgestrel; Risk; Sinus Thrombosis, Intracranial

2006
chemdatabank.com